CervoMed Inc
CRVO9.330USD
+0.500+5.66%
종가 08/04, 16:00（ET）시세는 15분 지연됩니다
81.20M시가총액
손실P/E TTM
자세한 내용은 CervoMed Inc 회사
CervoMed Inc. is a clinical-stage biotechnology company focused on developing treatments for age-related neurologic disorders. It is focused on the development of its lead drug candidate, neflamapimod, an investigational, orally administered, small molecule brain penetrant that inhibits p38a in the neurons (nerve cells) within the brains of people with neurodegenerative diseases. Its neflamapimod is in clinical development as a disease-modifying treatment for neurodegenerative diseases, such as dementia with Lewy Bodies and early Alzheimer’s disease. In addition, pre-clinical data supports the potential role of neflamapimod in recovery after stroke. Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in dementia with Lewy bodies (DLB) and certain other neurological disorders. It is being evaluated in its ongoing RewinD-LB Trial, a Phase 2b study in patients with DLB.
회사 정보
종목 코드 CRVO
회사 이름CervoMed Inc
상장일Nov 09, 2016
CEOMr. John J. Alam, M.D.
직원 수15
유형Ordinary Share
회계 연도 종료Nov 09
주소20 Park Plaza, Suite 424
도시BOSTON
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호02116
전화16177444400
웹사이트https://cervomed.com/
종목 코드 CRVO
상장일Nov 09, 2016
CEOMr. John J. Alam, M.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Joshua S. Boger, Ph.D.
Dr. Joshua S. Boger, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.06M
--
Mr. John J. Alam, M.D.
Mr. John J. Alam, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
730.79K
+0.17%
Mr. Jeffrey V. (Jeff) Poulton
Mr. Jeffrey V. (Jeff) Poulton
Independent Director
Independent Director
16.44K
--
Ms. Kelly Blackburn
Ms. Kelly Blackburn
Executive Vice President - Clinical Development
Executive Vice President - Clinical Development
13.67K
--
Ms. Jane H. Hollingsworth, M.D.
Ms. Jane H. Hollingsworth, M.D.
Independent Director
Independent Director
899.00
--
Mr. William R. Elder
Mr. William R. Elder
Chief Financial Officer, General Counsel, Corporate Secretary
Chief Financial Officer, General Counsel, Corporate Secretary
--
--
Dr. Marwan Noel Sabbagh, M.D.
Dr. Marwan Noel Sabbagh, M.D.
Independent Director
Independent Director
--
--
Dr. Claudia Ordonez, M.D.
Dr. Claudia Ordonez, M.D.
Senior Vice President - Medical Science
Senior Vice President - Medical Science
--
--
Dr. Marco Verwijs, Ph.D.
Dr. Marco Verwijs, Ph.D.
Executive Vice President - Technical Operations
Executive Vice President - Technical Operations
--
--
Dr. Robert J. Cobuzzi, Jr.
Dr. Robert J. Cobuzzi, Jr.
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Joshua S. Boger, Ph.D.
Dr. Joshua S. Boger, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.06M
--
Mr. John J. Alam, M.D.
Mr. John J. Alam, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
730.79K
+0.17%
Mr. Jeffrey V. (Jeff) Poulton
Mr. Jeffrey V. (Jeff) Poulton
Independent Director
Independent Director
16.44K
--
Ms. Kelly Blackburn
Ms. Kelly Blackburn
Executive Vice President - Clinical Development
Executive Vice President - Clinical Development
13.67K
--
Ms. Jane H. Hollingsworth, M.D.
Ms. Jane H. Hollingsworth, M.D.
Independent Director
Independent Director
899.00
--
Mr. William R. Elder
Mr. William R. Elder
Chief Financial Officer, General Counsel, Corporate Secretary
Chief Financial Officer, General Counsel, Corporate Secretary
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Boger (Joshua S)
12.15%
AWM Investment Company, Inc.
9.92%
Gregoire (Sylvie L.)
8.40%
Alam (John J)
8.40%
The Vanguard Group, Inc.
4.35%
Other
56.79%
주주
주주
비율
Boger (Joshua S)
12.15%
AWM Investment Company, Inc.
9.92%
Gregoire (Sylvie L.)
8.40%
Alam (John J)
8.40%
The Vanguard Group, Inc.
4.35%
Other
56.79%
주주 유형
주주
비율
Individual Investor
33.43%
Investment Advisor/Hedge Fund
14.17%
Investment Advisor
10.36%
Research Firm
1.60%
Hedge Fund
0.09%
Bank and Trust
0.06%
Pension Fund
0.02%
Other
40.27%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
117
5.20M
59.72%
-1.49M
2025Q1
117
5.20M
61.51%
-1.51M
2024Q4
109
4.40M
53.34%
-2.51M
2024Q3
92
6.43M
77.88%
-414.79K
2024Q2
78
6.37M
77.13%
+108.27K
2024Q1
52
5.40M
90.18%
+2.52M
2023Q4
54
3.10M
54.81%
+657.18K
2023Q3
54
3.32M
58.71%
+3.16M
2023Q2
46
125.98K
9.26%
-42.41K
2023Q1
54
143.15K
10.53%
-17.76K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Boger (Joshua S)
1.06M
12.15%
--
--
Apr 24, 2025
AWM Investment Company, Inc.
863.20K
9.92%
+863.20K
--
Mar 31, 2025
Gregoire (Sylvie L.)
730.79K
8.4%
-1.25K
-0.17%
Apr 24, 2025
Alam (John J)
730.79K
8.4%
+1.25K
+0.17%
Apr 24, 2025
The Vanguard Group, Inc.
378.66K
4.35%
-4.83K
-1.26%
Mar 31, 2025
Zavrl (Frank E.)
353.01K
4.06%
--
--
Apr 24, 2025
BlackRock Institutional Trust Company, N.A.
321.48K
3.69%
+24.03K
+8.08%
Mar 31, 2025
Morgan Stanley & Co. LLC
130.60K
1.5%
+87.90K
+205.86%
Mar 31, 2025
Geode Capital Management, L.L.C.
116.48K
1.34%
+1.65K
+1.43%
Mar 31, 2025
State Street Global Advisors (US)
112.06K
1.29%
-4.20K
-3.61%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Health Innovation Active ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
iShares Russell 2000 ETF
0%
ProShares Hedge Replication ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
비율0.01%
iShares Russell 2000 Growth ETF
비율0%
Global X Russell 2000 ETF
비율0%
Proshares Ultra Russell 2000
비율0%
ProShares UltraPro Russell2000
비율0%
iShares Health Innovation Active ETF
비율0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0%
iShares Russell 2000 ETF
비율0%
ProShares Hedge Replication ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Aug 16, 2023
Merger
1.5<1
Aug 16, 2023
Merger
1.5<1
Aug 16, 2023
Merger
1.5<1
Aug 16, 2023
Merger
1.5<1
Apr 18, 2022
Merger
50<1
Apr 18, 2022
Merger
50<1
날짜
유형
비율
Aug 16, 2023
Merger
1.5<1
Aug 16, 2023
Merger
1.5<1
Aug 16, 2023
Merger
1.5<1
Aug 16, 2023
Merger
1.5<1
Apr 18, 2022
Merger
50<1
Apr 18, 2022
Merger
50<1
Apr 18, 2022
Merger
50<1
Apr 18, 2022
Merger
50<1
